Show simple item record

dc.contributor.authorAl, Muzaffer
dc.contributor.authorTAŞKIN, Halit Eren
dc.date.accessioned2021-12-10T12:59:01Z
dc.date.available2021-12-10T12:59:01Z
dc.identifier.citationAl M., TAŞKIN H. E. , "Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes", SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021
dc.identifier.issn0930-2794
dc.identifier.othervv_1032021
dc.identifier.otherav_e662d72c-baf1-43fc-88ff-c1e43853e079
dc.identifier.urihttp://hdl.handle.net/20.500.12627/175147
dc.identifier.urihttps://doi.org/10.1007/s00464-021-08769-4
dc.description.abstractBackground At least 25 metabolic/bariatric procedures have been proposed globally, 5 formally endorsed. A newer procedure, sleeve gastrectomy with transit bipartition (SG + TB), appears to markedly reduce weight and improve metabolic syndrome while being relatively simple technically and protective of long-term nutritional stability. We aimed to investigate SG + TB effectiveness and safety. Methods In a single-center retrospective analysis of prospectively collected data, SG + TB patients were followed through 12 months. Primary outcomes were changes in weight [body mass index (BMI), total weight loss (TWL)], metabolic parameters [HbA1(C), LDL cholesterol, triglycerides (TG), hypertension], and nutritional status. Repeated-measures analysis of variance (ANOVA) was used to assess changes in weight and metabolic parameters at 1, 3, 6, 9, and 12 months after surgery. Results Between 2015 and 2019, 883 patients (mean age 51.8 yrs, BMI 34.1 +/- 5.0 kg/m(2)) underwent SG + TB. Mean operative time was 124 +/- 25.4 min; hospitalization, 4.0 +/- 2.5 days. ANOVA indicated significant reductions in weight and metabolic parameters (p < 0.005). In 646 patients with complete weight data at 12 months, mean BMI was reduced to 27.2 +/- 3.4 kg/m(2) (p < 0.001), TWL 19.8 +/- 6.0%. HbA1(C) was normalized in 83.3% of SG + TB patients; hyperlipidemia, hypertension, and hypertriglyceridemia were significantly reduced (p < 0.001). Also, there was a significant reduction in the proportion of patients outside normal nutritional reference ranges. The overall complication rate was 10.2%. There was no mortality. Conclusion In a series of 833 lower-BMI patients who underwent SG + TB and were followed through 12 months (73.2% follow-up), significant weight loss, comorbidity reduction, and nutritional stability were attained with few major complications and no mortality.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSurgery
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCERRAHİ
dc.titleSleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes
dc.typeMakale
dc.relation.journalSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
dc.contributor.departmentYakın Doğu Üniversitesi , ,
dc.contributor.firstauthorID2757904


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record